This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Monday, November 5, 2012
Radio host - 15-year anniversary today of a successful liver transplant
Radio show host calls organ donors heroes
K100's Steele in 15th year of new life
BY VANESSA McCRAY
BLADE STAFF WRITER
The year was 1997, and the Toledo radio personality didn’t feel great. His appearance changed, too. He was bloated and had gained so much weight in his lower gut that his children began calling him Buddha. Then, in early August he noticed something else.
“I looked in the mirror, and my eyes had turned yellow,” Mr. Steele said.
The following days and months would alter his life. Doctors said hepatitis C--contracted through a tainted blood transfusion for a bleeding ulcer that occurred 12 years before--was destroying his liver. He needed a new one.
Today, he marks the 15th anniversary of a successful liver transplant and the fresh start made possible through organ donation.
Continue reading....
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment